Polsinelli

Led by Shareholder Christopher Simpson and including Izzy Drake, we recently represented Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, in a multi-target collaboration and license agreement with Biogen to advance the use of Alloy’s AntiClastic™ A*O Platform, an antisense oligonucleotide technology used to support the design and development of therapeutics: https://www.polsinelli.com/news/polsinelli-represents-alloy-aso-platform-collaboration-biogen.

Our attorneys recently attended the 2026 Mas Family Scholarships Golf Tournament in Miami, where we were proud to serve as a silver sponsor in support of our client, MasTec. Our team has built a strong partnership with MasTec over the past decade, particularly in the employment space, and it was a pleasure to connect in person while supporting a meaningful cause focused on expanding educational opportunities. We’re grateful for the opportunity to support this impactful event and to continue strengthening our longstanding client relationships.

Seldom does a brand get go-to-market right on the first try. There are hard lessons learned, pivots and re-pivots. All in the interest of finding a long-term and profitable home on that shelf. Join David Cykiert, Bill Di Bianca and Adam Greene as they speak with investors in and founders of your favorite CPG brands, Ariana Farahani, Jonathan Srour and Kyle Widrick, to learn what they’ve done right, what they’ve done wrong and what they’re still trying to figure out at our Polsinelli Pulse Series on Thursday, April 16 in our New York office: https://sites-polsinelli.vuturevx.com/133/6284/landing-pages/rsvp-blank.asp?sid=b0f4298f-b367-4ffe-bdb9-2c3bc9a8e4a7.

Please join us in congratulating Thomas Hohenstein on being named to Missouri Lawyers Media's The POWER List: Construction Law 2026: https://molawyersmedia.com/2026/03/12/the-power-list-construction-law-2026/.